Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Leuk Res ; 37(1): 117-9, 2013 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-23127356

RESUMO

Chronic myeloid leukaemia (CML) is characterized by the Philadelphia chromosome resulting in the BCR-ABL1 gene whose mRNA transcript detection is commonly used for diagnosis and monitoring of therapeutic response. However, in collected blood specimen degradation of mRNA has to be considered during storage and transport thus jeopardizing the analysis. We here describe an alternative DNA-based technique applied after long-term blood storage. DNA was isolated from dried blood stains from CML patients stored on filter paper (Guthrie cards) after a median period from diagnosis of 11 years (range: 5-12 years) and analyzed with a two round long-range multiplex PCR (MLR-PCR) to identify the genomic BCR-ABL1 breakpoint. Patient-specific individual BCR-ABL1 fusion sites were successfully detected in 10 out of 13 patients. Dried blood stains represent a valuable resource for genomic DNA analyses. Long term preservation is easily manageable in paper envelopes with the patient's medical files with a minimum of financial costs and efforts. Such the cooperation between laboratories and hospitals separated by long distances is facilitated rendering possible offering specialized genomic analyses to patients with CML virtually everywhere around the world. This technique may also be a valuable approach for diagnostic procedures on a high molecular level in related haematological malignancies.


Assuntos
Proteínas de Fusão bcr-abl/genética , Leucemia Mielogênica Crônica BCR-ABL Positiva/genética , Adolescente , Adulto , Criança , Pré-Escolar , Feminino , Proteínas de Fusão bcr-abl/sangue , Fusão Gênica , Humanos , Masculino
2.
PLoS One ; 6(8): e22925, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21857969

RESUMO

BACKGROUND: Poor adherence is estimated to cause 125 thousand deaths per year and is linked to 10% of all hospital stays in the U.S. Up to one third of elderly hypertensive patients don't have adherence, which is responsible for high proportion of hospitalizations. Hypertension is also related to poor performance in tests that assess cognitive functions. On the other hand, poor cognitive performance is associated with low adherence to treatment. OBJECTIVE: To assess the association between cognitive function, anxiety and psychiatric disorders with adherence to drug treatment in patients with hypertension. METHODOLOGY AND PRINCIPAL FINDINGS: This a cohort studies with 56 adult patients with uncontrolled hypertension who participated of all meetings of a pharmaceutical intervention in a randomized clinical trial of pharmaceutical care. Cognitive function was measured by the Mini Mental State Examination (Mini-mental). The memory was measured by digit and word spans, tower and church shadow test, short story test and metamemory. Anxiety and psychiatric disorders were evaluated by the State Trace Anxiety Inventory and the Self-Report Questionnaire, respectively. The participants were classified as adherent or non-adherent to the drug treatment, according to the identification of plasma levels of hydrochlorothiazide. All non-adherent patients (n = 12) and 35 out 44 (79.5%) patients with adherence to treatment had at least one memory test with an altered score (P = 0.180). Participants with an unsatisfactory score in the Mini-mental had six-fold higher risk of non-adherence to treatment when compared to those with a normal score (RR = 5.8; CI 95%: 1.6-20.8; P = 0.007). The scores of anxiety and psychiatric disorders were not associated with adherence to the pharmacological treatment. CONCLUSION: Cognitive deficit impairs adherence to drug therapy and should be screened as part of a program of pharmaceutical care to improve adherence to treatment.


Assuntos
Ansiedade/fisiopatologia , Cognição/fisiologia , Hidroclorotiazida/uso terapêutico , Hipertensão/tratamento farmacológico , Adesão à Medicação/psicologia , Transtornos Mentais/fisiopatologia , Idoso , Anti-Hipertensivos/uso terapêutico , Estudos de Coortes , Feminino , Humanos , Hipertensão/fisiopatologia , Hipertensão/psicologia , Masculino , Pessoa de Meia-Idade , Análise de Regressão , Inquéritos e Questionários
3.
Rev. bras. hipertens ; 13(3): 198-202, jun.-set. 2006.
Artigo em Português | LILACS | ID: lil-437580

RESUMO

Atenção farmacêutica é uma nova prática profissional baseada em ações pró-ativas recomendadas pela Organização Mundial da Saúde (OMS), Associações Médicas Internacionais e pelo Conselho Nacional de Saúde do Brasil. Sua implementação entre as práticas de atenção à saúde pode contribuir para a resolução de problemas de saúde pública. Os primeiros estudos realizados, para avaliar a efetividade dessa intervenção no tratamento de pacientes hipertensos não-controlados, demonstram sua exeqüibilidade e potencial contribuição para o controle da hipertensão


Assuntos
Humanos , Hipertensão/terapia , Assistência Farmacêutica , Anti-Hipertensivos/uso terapêutico , Seguimentos , Hipertensão/tratamento farmacológico , Farmacêuticos , Assistência Farmacêutica
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA